National, 15th January, 2026: Aerolase, a global pioneer in laser skin health, has been honored with two awards at the 2025 MedEsthetics Readers’ Choice Awards. This prestigious recognition, voted exclusively by dermatologists, plastic surgeons, and aesthetic experts, celebrates real-world clinical results and innovative breakthroughs in medical aesthetics. Unlike conventional jury-selected awards, the Readers’ Choice Awards are driven entirely by peer votes, underscoring Aerolase’s proven impact and trusted reputation in the field of laser skin treatments.
The MedEsthetics Readers’ Choice Awards are conferred on technologies that demonstrate consistent clinical performance, safety, and practitioner confidence across high-volume practices. Neo Elite® clinched Best Acne Treatment, solidifying its dominance in tackling acne across all Fitzpatrick skin types. This powerhouse 1064 nm Nd:YAG laser platform treats over 36 dermatological conditions with zero downtime, minimal discomfort, and contactless delivery, delivering up to 80% acne reduction by treatment end, sustained results at follow-up, and rave patient reviews.
Era Elite® earned Finalist status in Best Laser Skin Resurfacing Device, showcasing Aerolase’s edge in regenerative tech. As the only erbium laser offering precise ablation without thermal damage, it transforms resurfacing for Fitzpatrick V-VI skin types, unlocking smoother, rejuvenated results with downtime under 24 hours.
Commenting on the recognition, Mr. Madhusudhan HK, Country Head, Aerolase, said, “This peer-driven recognition from the global medical aesthetics community is especially meaningful as it is based on real-world clinical outcomes and practitioner experience. In India’s booming skincare market, projected to hit $1.86 billion by 2028, aesthetic clinics face soaring demand for inclusive, efficient solutions. Neo Elite® slashes treatment times by 50% for high-volume practices, while Era Elite® expands access to darker skin tones, boosting patient satisfaction and revenue without compromising safety. It reinforces our commitment to developing laser technologies that deliver effective, regenerative results without pain, downtime or limitations across skin types.”
These wins affirm Aerolase’s grip on technologies that excel in safety, speed, and scalability for busy global clinics. The company remains committed to advancing regenerative solutions that align with the evolving needs of dermatology and aesthetic practices.
About Aerolase
Aerolase is a global technology leader in laser skin health and the sole developer and manufacturer of portable high-power lasers for dermatology and aesthetic applications. Founded in 1996 and headquartered in Tarrytown, New York, the company offers advanced laser systems designed to treat a wide range of medical and aesthetic skin conditions across all skin types. Aerolase’s devices are known for their contactless treatment approach, ensuring a hygienic and comfortable experience for patients. The company’s flagship products, including the Neo Elite and Era Elite, are FDA-cleared for multiple indications and are utilized by dermatologists, plastic surgeons, and medical spas in over 55 countries worldwide.
